The Mechanism of Tigecycline Resistance in Acinetobacter baumannii Revealed by Proteomic and Genomic Analysis
暂无分享,去创建一个
Ping-Zhang Wang | Lei Wang | Q. Zou | D. Xiao | Cunwei Liu | Qing-hua Zou
[1] Qinghua Zou,et al. Fitness Costs of Tigecycline Resistance in Acinetobacter baumannii and the Resistance Mechanism Revealed by a Transposon Mutation Library , 2022, Antibiotics.
[2] R. Bonomo,et al. Involvement of the Histone-Like Nucleoid Structuring Protein (H-NS) in Acinetobacter baumannii’s Natural Transformation , 2021, Pathogens.
[3] R. Bonomo,et al. Histone-like nucleoid-structuring protein (H-NS) regulatory role in antibiotic resistance in Acinetobacter baumannii , 2021, Scientific Reports.
[4] I. Rasooli,et al. A conserved region of Acinetobacter trimeric autotransporter adhesion, Ata, provokes suppression of Acinetobacter baumannii virulence , 2021, Archives of Microbiology.
[5] S. Dove,et al. H‐NS‐like proteins in Pseudomonas aeruginosa coordinately silence intragenic transcription , 2020, Molecular microbiology.
[6] G. Abirami,et al. Gene expressing analysis indicates the role of Pyrogallol as a novel antibiofilm and antivirulence agent against Acinetobacter baumannii , 2020, Archives of microbiology.
[7] Chul Hee Choi,et al. Regulation of the AcrAB efflux system by the quorum-sensing regulator AnoR in Acinetobacter nosocomialis , 2020, Journal of Microbiology.
[8] R. Bonomo,et al. The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in Acinetobacter baumannii , 2020, mSphere.
[9] Michael Sadler,et al. Characterization of the IS200/IS605 Insertion Sequence Family in Halanaerobium Hydrogeniformans , 2020, Genes.
[10] D. Álvarez-Hernández,et al. Acinetobacter baumannii Resistance: A Real Challenge for Clinicians , 2020, Antibiotics.
[11] C. Ayoub Moubareck,et al. Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen , 2020, Antibiotics.
[12] Devyani Samantarrai,et al. TonB-Dependent Transporters in Sphingomonads: Unraveling Their Distribution and Function in Environmental Adaptation , 2020, Microorganisms.
[13] Jianzhong Shen,et al. Novel Plasmid-Mediated tet(X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate , 2019, Antimicrobial Agents and Chemotherapy.
[14] R. Isberg,et al. Acinetobacter baumannii: Envelope Determinants That Control Drug Resistance, Virulence, and Surface Variability. , 2019, Annual review of microbiology.
[15] Xiaokang Wu,et al. iTRAQ-Based Differential Proteomic Analysis Reveals the Pathways Associated with Tigecycline Resistance in Acinetobacter baumannii , 2018, Cellular Physiology and Biochemistry.
[16] Chul Hee Choi,et al. Local Repressor AcrR Regulates AcrAB Efflux Pump Required for Biofilm Formation and Virulence in Acinetobacter nosocomialis , 2018, Front. Cell. Infect. Microbiol..
[17] Lidan Chen,et al. In Vitro Activity of Various Antibiotics in Combination with Tigecycline Against Acinetobacter baumannii: A Systematic Review and Meta-Analysis. , 2017, Microbial drug resistance.
[18] Haixu Tang,et al. ISEScan: automated identification of insertion sequence elements in prokaryotic genomes , 2017, Bioinform..
[19] M. Hamidian,et al. A large conjugative Acinetobacter baumannii plasmid carrying the sul2 sulphonamide and strAB streptomycin resistance genes. , 2016, Plasmid.
[20] E. Pohl,et al. The Effectors and Sensory Sites of Formaldehyde-responsive Regulator FrmR and Metal-sensing Variant * , 2016, The Journal of Biological Chemistry.
[21] J. Quan,et al. Abrp, a new gene, confers reduced susceptibility to tetracycline, glycylcine, chloramphenicol and fosfomycin classes in Acinetobacter baumannii , 2016, European Journal of Clinical Microbiology & Infectious Diseases.
[22] B. Fu,et al. Characterization of surface antigen protein 1 (SurA1) from Acinetobacter baumannii and its role in virulence and fitness. , 2016, Veterinary microbiology.
[23] Z. Qinghua,et al. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae. , 2016, Revista da Sociedade Brasileira de Medicina Tropical.
[24] F. Corona,et al. Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants , 2016, Microorganisms.
[25] Xi Li,et al. Complete genome sequence of Acinetobacter baumannii XH386 (ST208), a multi-drug resistant bacteria isolated from pediatric hospital in China , 2015, Genomics data.
[26] S. Pournaras,et al. In Vitro Activity of Tigecycline Against Acinetobacter baumannii: Global Epidemiology and Resistance Mechanisms. , 2016, Advances in experimental medicine and biology.
[27] S. Pukatzki,et al. A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii , 2015, Proceedings of the National Academy of Sciences.
[28] J. L. Shen,et al. LC-MS/MS: a rapid and simple new method for the determination of carbapenem β-lactamases. , 2015, Genetics and molecular research : GMR.
[29] Youjun Feng,et al. Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[30] P. Siguier,et al. Bacterial insertion sequences: their genomic impact and diversity , 2014, FEMS microbiology reviews.
[31] Xi Li,et al. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase. , 2014, The Journal of antimicrobial chemotherapy.
[32] J. Sheng,et al. Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital , 2013, Antimicrobial Agents and Chemotherapy.
[33] J. Vila,et al. Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.
[34] L. Piddock,et al. A Method for generating marker-less gene deletions in multidrug-resistant Acinetobacter baumannii , 2013, BMC Microbiology.
[35] Jianping Xie,et al. The underling mechanism of bacterial TetR/AcrR family transcriptional repressors. , 2013, Cellular signalling.
[36] P. Courvalin,et al. RND-Type Efflux Pumps in Multidrug-Resistant Clinical Isolates of Acinetobacter baumannii: Major Role for AdeABC Overexpression and AdeRS Mutations , 2013, Antimicrobial Agents and Chemotherapy.
[37] L. Piddock,et al. Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm. , 2012, The Journal of antimicrobial chemotherapy.
[38] S. Amyes,et al. Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins. , 2012, Journal of medical microbiology.
[39] W. Pirovano,et al. Toward almost closed genomes with GapFiller , 2012, Genome Biology.
[40] Sergey I. Nikolenko,et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..
[41] J. Vila,et al. The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace , 2012, Front. Microbio..
[42] M. Weiss,et al. Structural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenase , 2011, FEBS letters.
[43] Karl A. Hassan,et al. Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions , 2011, BMC Genomics.
[44] J. Rougemont,et al. Primer-initiated sequence synthesis to detect and assemble structural variants , 2010, Nature Methods.
[45] P. Bradford,et al. RT-PCR and statistical analyses of adeABC expression in clinical isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex. , 2010, Microbial drug resistance.
[46] P. Courvalin,et al. Screening and Quantification of the Expression of Antibiotic Resistance Genes in Acinetobacter baumannii with a Microarray , 2009, Antimicrobial Agents and Chemotherapy.
[47] A. Yamaguchi,et al. H-NS Modulates Multidrug Resistance of Salmonella enterica Serovar Typhimurium by Repressing Multidrug Efflux Genes acrEF , 2009, Antimicrobial Agents and Chemotherapy.
[48] P. Bradford,et al. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. , 2007, The Journal of antimicrobial chemotherapy.
[49] P. Nordmann,et al. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[50] A. Yamaguchi,et al. Role of Histone-Like Protein H-NS in Multidrug Resistance of Escherichia coli , 2004, Journal of bacteriology.
[51] L. Actis,et al. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. , 2003, Microbiology.
[52] N. Caroff,et al. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. , 2003, The Journal of antimicrobial chemotherapy.
[53] I. Odenholt. Pharmacodynamic effects of subinhibitory antibiotic concentrations. , 2001, International journal of antimicrobial agents.
[54] K. Poole,et al. Influence of the TonB Energy-Coupling Protein on Efflux-Mediated Multidrug Resistance in Pseudomonas aeruginosa , 1998, Antimicrobial Agents and Chemotherapy.
[55] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[56] J. Duval,et al. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods , 1994, Journal of clinical microbiology.